Lipocalin-2 (LCN-2) is a biomarker of kidney injury [103] and its levels are reported to increase, both in serum and urine, in patients with AKI [104], whereas tumor necrosis factor-alpha (TNF-α) is a cytokine and major regulator of inflammatory response following kidney injury [105]. This evidence concerns the gene TNF and acute kidney injury.